Ropes & Gray Represents ConvaTec Group in its Acquisition of Triad Life Sciences
Ropes & Gray represented ConvaTec Group, a global medical solutions company, in its acquisition of medical device company, Triad Life Sciences.
Under the merger agreement, which is subject to Hart-Scott-Rodino approval, ConvaTec will pay $125 million at closing, followed by two payments of $25 million each if certain short-term milestones are reached, and additional potential payments of up to $275 million if certain financial performance targets are met within the first two years. The transaction was announced on Jan. 28 in a press release.
The Ropes team that represented ConvaTec is led by private capital transactions partner Timothy Castelli (Chicago) and private capital transactions associate Andrew Pomranke (Chicago), and includes strategic transactions partner Melissa Rones (Boston), health care partner Christina Bergeron (Boston), employment, executive compensation & benefits partner Matt Jones (Chicago), life sciences regulatory & compliance partner Kellie Combs (Washington, D.C.), IP transactions partner Amanda Austin (Boston), strategic transactions counsel Ryan Murphey (New York), litigation & enforcement counsel Bill Kearney (Washington, D.C.), litigation & enforcement partner Jane Willis (Boston) and tax partner Benjamin Rogers (San Francisco).